NO20091642L - [2- (6-fluoro-1H-indol-3-ylsulfanyl) benzyl] methylamine for the treatment of affective disorders - Google Patents

[2- (6-fluoro-1H-indol-3-ylsulfanyl) benzyl] methylamine for the treatment of affective disorders

Info

Publication number
NO20091642L
NO20091642L NO20091642A NO20091642A NO20091642L NO 20091642 L NO20091642 L NO 20091642L NO 20091642 A NO20091642 A NO 20091642A NO 20091642 A NO20091642 A NO 20091642A NO 20091642 L NO20091642 L NO 20091642L
Authority
NO
Norway
Prior art keywords
ylsulfanyl
indol
methylamine
fluoro
benzyl
Prior art date
Application number
NO20091642A
Other languages
Norwegian (no)
Inventor
Jan Kehler
Karsten Juhl
Neil Anderson
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2007/000419 external-priority patent/WO2008037258A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20091642L publication Critical patent/NO20091642L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

[2-(6-fluor-1H-indol-3-ylsulfanyl)benzyl]metylamin og farmasøytisk akseptable salter derav, forutsatt at det ikke er den frie basen i en ikke-krystallinsk form, tilveiebringes for behandlingen av affektive lidelser.[2- (6-Fluoro-1H-indol-3-ylsulfanyl) benzyl] methylamine and pharmaceutically acceptable salts thereof, provided that it is not the free base in a non-crystalline form, are provided for the treatment of affective disorders.

NO20091642A 2006-09-28 2009-04-27 [2- (6-fluoro-1H-indol-3-ylsulfanyl) benzyl] methylamine for the treatment of affective disorders NO20091642L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200601251 2006-09-28
DKPA200700432 2007-03-20
PCT/DK2007/000419 WO2008037258A1 (en) 2006-09-28 2007-09-27 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders

Publications (1)

Publication Number Publication Date
NO20091642L true NO20091642L (en) 2009-04-27

Family

ID=40225153

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091642A NO20091642L (en) 2006-09-28 2009-04-27 [2- (6-fluoro-1H-indol-3-ylsulfanyl) benzyl] methylamine for the treatment of affective disorders

Country Status (8)

Country Link
KR (1) KR20090074749A (en)
AR (1) AR062981A1 (en)
BR (1) BRPI0717038A2 (en)
CL (1) CL2007002789A1 (en)
EA (1) EA200970325A1 (en)
IL (1) IL197720A0 (en)
NO (1) NO20091642L (en)
TW (1) TW200829550A (en)

Also Published As

Publication number Publication date
KR20090074749A (en) 2009-07-07
BRPI0717038A2 (en) 2013-10-01
EA200970325A1 (en) 2009-12-30
AR062981A1 (en) 2008-12-17
TW200829550A (en) 2008-07-16
CL2007002789A1 (en) 2008-04-18
IL197720A0 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
NO2017036I1 (en) Daklatasvir and its pharmaceutically acceptable salts, especially daclatasvir dihydrochloride
CY1122687T1 (en) COMPOSITIONS AND METHODS FOR MODULATING SMN2 SPECIFICATION IN A SUBJECT
NO20065878L (en) Therapeutic compounds
BRPI0507224A (en) method and device for the treatment of obstructive sleep apnea and snoring
NO20064792L (en) Use of rotigotine for the treatment and connection of Parkinson's plus syndrome.
ZA200900228B (en) N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
DK2023918T3 (en) Cyclosporins for the treatment and prevention of ocular disorders
ATE453637T1 (en) N-(AMINOHETEROARYL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES AND THEIR PRODUCTION AND THERAPEUTIC USE
ATE420639T1 (en) ANTIFUNGAL AGENTS
NO20062150L (en) New ketooksadiazole derivatives as catheps inhibitors
SE0401342D0 (en) Therapeutic compounds
MX352516B (en) Therapeutic compounds.
NO20082112L (en) 3-Amino-2-arylpropylazaindoles and their use
NO20084282L (en) New crystalline form of (5S) -5- [4- (5-chloropyridin-2-yloxy) piperidine-1-sulfonylmethyl] -5-methylimidazoline-2,4-dione (1) and intermediates thereof
CY1110170T1 (en) N-CARBAMOYLMETHYL-4 (-R) -PHENYL-2-PYRROLIDINONE, METHOD OF PREPARATION AND PHARMACEUTICAL USE
MX2010003989A (en) Composition 064.
NO20092634L (en) Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
EA201001857A1 (en) PHARMACEUTICAL MEDICINE FORM FOR IMMEDIATE RELEASE OF INDOLINON DERIVATIVE
MX2019002615A (en) Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making.
EP4027935A4 (en) Lingual positioning device for sleep, breathing, jaw and airway disorders
PE20211818A1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INCLUDING A DERIVATIVE OF AMINOPYRIMIDINE OR ITS SALT
RU2007122391A (en) S-MIRTAZAPINE FOR TIDAL TREATMENT
MX2009003299A (en) [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders.
MX2009003974A (en) N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression.
NO20082130L (en) 3-Amino-1-arylpropylindoles and aza-substituted indoles

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application